BridgeBio Pharma to Discuss Additional Data from the Phase 3 ATTRibute-CM Study as Presented at AHA 11.12.2023 at 11:15 AM EST Click here for webcast Supporting Materials BBIO-ATTRibute-CM AHA Webcast 1.8 MB